{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:48:14Z","timestamp":1740138494550,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20150331689"],"award-info":[{"award-number":["DEQ20150331689"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12035-018-1193-7","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T10:29:48Z","timestamp":1531304988000},"page":"2159-2173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases"],"prefix":"10.1007","volume":"56","author":[{"given":"Th\u00e9o Z.","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Martin-Lanner\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Reine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hernandez-Rapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Dron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Privat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Passet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Halliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Villa-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Lacroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ha\u00efk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Andr\u00e9oletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Maria","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Vilotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"B\u00e9ringue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8950-1949","authenticated-orcid":false,"given":"Sophie","family":"Mouillet-Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1152\/physrev.00006.2009","volume":"89","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A, Calella AM (2009) Prions: Protein aggregation and infectious diseases. Physiol Rev 89:1105\u20131152","journal-title":"Physiol Rev"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molmed.2010.09.001","volume":"17","author":"C Soto","year":"2011","unstructured":"Soto C, Satani N (2011) The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 17:14\u201324. \n                    https:\/\/doi.org\/10.1016\/j.molmed.2010.09.001","journal-title":"Trends Mol Med"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"13148","DOI":"10.1073\/pnas.93.23.13148","volume":"93","author":"S Brandner","year":"1996","unstructured":"Brandner S, Raeber A, Sailer A, Blattler T, Fischer M, Weissmann C, Aguzzi A (1996) Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci U A 93:13148\u201313151","journal-title":"Proc Natl Acad Sci U A"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H Bueler","year":"1993","unstructured":"Bueler H, Aguzzi A, Sailer A et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339\u20131347","journal-title":"Cell"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C et al (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435\u20131439","journal-title":"Science"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.1090187","volume":"302","author":"G Mallucci","year":"2003","unstructured":"Mallucci G, Dickinson A, Linehan J, Kl\u00f6hn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871\u2013874","journal-title":"Science"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biochi.2014.06.009","volume":"104C","author":"TZ Hirsch","year":"2014","unstructured":"Hirsch TZ, Hernandez-Rapp J, Martin-Lanneree S et al (2014) PrPC signalling in neurons: From basics to clinical challenges. Biochimie 104C:2\u201311","journal-title":"Biochimie"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.06.001","volume":"150","author":"TZ Hirsch","year":"2017","unstructured":"Hirsch TZ, Martin-Lanner\u00e9e S, Mouillet-Richard S (2017) Functions of the prion protein. Prog Mol Biol Transl Sci 150:1\u201334. \n                    https:\/\/doi.org\/10.1016\/bs.pmbts.2017.06.001","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12402","volume":"501","author":"T Sonati","year":"2013","unstructured":"Sonati T, Reimann RR, Falsig J, Baral PK, O\u2019Connor T, Hornemann S, Yaganoglu S, Li B et al (2013) The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501:102\u2013106. \n                    https:\/\/doi.org\/10.1038\/nature12402","journal-title":"Nature"},{"key":"1193_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004531","volume":"10","author":"S Sorce","year":"2014","unstructured":"Sorce S, Nuvolone M, Keller A, Falsig J, Varol A, Schwarz P, Bieri M, Budka H et al (2014) The role of the NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathog 10:e1004531. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1004531","journal-title":"PLoS Pathog"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature11058","volume":"485","author":"JA Moreno","year":"2012","unstructured":"Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, Halliday M, Morgan J et al (2012) Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485:507\u2013511. \n                    https:\/\/doi.org\/10.1038\/nature11058","journal-title":"Nature"},{"key":"1193_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.3302","volume":"19","author":"M Pietri","year":"2013","unstructured":"Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A, Mouillet-Richard S, Haik S et al (2013) PDK1 decreases TACE-mediated \u03b1-secretase activity and promotes disease progression in prion and Alzheimer\u2019s diseases. Nat Med 19:1124\u20131131. \n                    https:\/\/doi.org\/10.1038\/nm.3302","journal-title":"Nat Med"},{"key":"1193_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005073","volume":"11","author":"A Alleaume-Butaux","year":"2015","unstructured":"Alleaume-Butaux A, Nicot S, Pietri M, Baudry A, Dakowski C, Tixador P, Ardila-Osorio H, Haeberl\u00e9 AM et al (2015) Double-edge sword of sustained ROCK activation in prion diseases through Neuritogenesis defects and prion accumulation. PLoS Pathog 11:e1005073. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1005073","journal-title":"PLoS Pathog"},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1038\/s41598-017-08110-x","volume":"7","author":"J Ezpeleta","year":"2017","unstructured":"Ezpeleta J, Boudet-Devaud F, Pietri M, Baudry A, Baudouin V, Alleaume-Butaux A, Dagoneau N, Kellermann O et al (2017) Protective role of cellular prion protein against TNF\u03b1-mediated inflammation through TACE \u03b1-secretase. Sci Rep 7:7671. \n                    https:\/\/doi.org\/10.1038\/s41598-017-08110-x","journal-title":"Sci Rep"},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1096\/fj.11-185579","volume":"26","author":"D Loubet","year":"2012","unstructured":"Loubet D, Dakowski C, Pietri M, Pradines E, Bernard S, Callebert J, Ardila-Osorio H, Mouillet-Richard S et al (2012) Neuritogenesis: The prion protein controls \u03b21 integrin signaling activity. FASEB J off Publ fed am Soc. Exp Biol 26:678\u2013690. \n                    https:\/\/doi.org\/10.1096\/fj.11-185579","journal-title":"Exp Biol"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/stem.2501","volume":"35","author":"S Martin-Lanner\u00e9e","year":"2017","unstructured":"Martin-Lanner\u00e9e S, Halliez S, Hirsch TZ, Hernandez-Rapp J, Passet B, Tomkiewicz C, Villa-Diaz A, Torres JM et al (2017) The cellular prion protein controls notch signaling in neural stem\/progenitor cells. Stem Cells 35:754\u2013765. \n                    https:\/\/doi.org\/10.1002\/stem.2501","journal-title":"Stem Cells"},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrn1847","volume":"7","author":"A Louvi","year":"2006","unstructured":"Louvi A, Artavanis-Tsakonas S (2006) Notch signalling in vertebrate neural development. Nat Rev Neurosci 7:93\u2013102","journal-title":"Nat Rev Neurosci"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrn3024","volume":"12","author":"JL Ables","year":"2011","unstructured":"Ables JL, Breunig JJ, Eisch AJ, Rakic P (2011) Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci 12:269\u2013283. \n                    https:\/\/doi.org\/10.1038\/nrn3024","journal-title":"Nat Rev Neurosci"},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"23782","DOI":"10.1074\/jbc.M802433200","volume":"283","author":"S Mouillet-Richard","year":"2008","unstructured":"Mouillet-Richard S, Nishida N, Pradines E, Laude H, Schneider B, F\u00e9raudet C, Grassi J, Launay JM et al (2008) Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells. J Biol Chem 283:23782\u201323790","journal-title":"J Biol Chem"},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrd4175","volume":"13","author":"AW Boyd","year":"2014","unstructured":"Boyd AW, Bartlett PF, Lackmann M (2014) Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov 13:39\u201362. \n                    https:\/\/doi.org\/10.1038\/nrd4175","journal-title":"Nat Rev Drug Discov"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mcn.2012.03.004","volume":"50","author":"M Hruska","year":"2012","unstructured":"Hruska M, Dalva MB (2012) Ephrin regulation of synapse formation, function and plasticity. Mol Cell Neurosci 50:35\u201344. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2012.03.004","journal-title":"Mol Cell Neurosci"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1099\/vir.0.83344-0","volume":"89","author":"M-P Courageot","year":"2008","unstructured":"Courageot M-P, Daude N, Nonno R, Paquet S, di Bari MA, le Dur A, Chapuis J, Hill AF et al (2008) A cell line infectible by prion strains from different species. J Gen Virol 89:341\u2013347. \n                    https:\/\/doi.org\/10.1099\/vir.0.83344-0","journal-title":"J Gen Virol"},{"key":"1193_CR23","doi-asserted-by":"publisher","first-page":"e00829","DOI":"10.1128\/mBio.00829-13","volume":"5","author":"M Moudjou","year":"2013","unstructured":"Moudjou M, Sibille P, Fichet G et al (2013) Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification. mBio 5:e00829\u2013e00813. \n                    https:\/\/doi.org\/10.1128\/mBio.00829-13","journal-title":"mBio"},{"key":"1193_CR24","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1073\/pnas.90.22.10608","volume":"90","author":"SB Prusiner","year":"1993","unstructured":"Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL et al (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U A 90:10608\u201310612","journal-title":"Proc Natl Acad Sci U A"},{"key":"1193_CR25","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1523\/JNEUROSCI.0693-07.2007","volume":"27","author":"V B\u00e9ringue","year":"2007","unstructured":"B\u00e9ringue V, Andr\u00e9oletti O, Le Dur A et al (2007) A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J Neurosci 27:6965\u20136971. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0693-07.2007","journal-title":"J Neurosci"},{"key":"1193_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02780662","volume":"8","author":"JC Manson","year":"1994","unstructured":"Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129\/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8:121\u2013127","journal-title":"Mol Neurobiol"},{"key":"1193_CR27","doi-asserted-by":"crossref","unstructured":"Herva ME, Relano-Gines A, Villa A, Torres JM (2010) Prion infection of differentiated neurospheres. J Neurosci Methods 2010:3","DOI":"10.1016\/j.jneumeth.2010.02.022"},{"issue":"10","key":"1193_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-016-0284-9","volume":"4","author":"J Chapuis","year":"2016","unstructured":"Chapuis J, Moudjou M, Reine F, Herzog L, Jaumain E, Chapuis C, Quadrio I, Boulliat J et al (2016) Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Acta Neuropathol Commun 4(10):10. \n                    https:\/\/doi.org\/10.1186\/s40478-016-0284-9","journal-title":"Acta Neuropathol Commun"},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/j.1460-9568.2011.07910.x","volume":"34","author":"V Kiyasova","year":"2011","unstructured":"Kiyasova V, Gaspar P (2011) Development of raphe serotonin neurons from specification to guidance. Eur J Neurosci 34:1553\u20131562. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07910.x","journal-title":"Eur J Neurosci"},{"key":"1193_CR30","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1073\/pnas.1314523111","volume":"111","author":"S J\u00e4gle","year":"2014","unstructured":"J\u00e4gle S, R\u00f6nsch K, Timme S, Andrlov\u00e1 H, Bertrand M, J\u00e4ger M, Proske A, Schrempp M et al (2014) Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer. Proc Natl Acad Sci U S A 111:4886\u20134891. \n                    https:\/\/doi.org\/10.1073\/pnas.1314523111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1193_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcyt.2014.12.003","volume":"17","author":"H Kim","year":"2015","unstructured":"Kim H, Huang L, Critser PJ, Yang Z, Chan RJ, Wang L, carlesso N, Voytik-Harbin SL et al (2015) Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cells. Cytotherapy 17:579\u2013592. \n                    https:\/\/doi.org\/10.1016\/j.jcyt.2014.12.003","journal-title":"Cytotherapy"},{"key":"1193_CR32","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1242\/dev.125724","volume":"142","author":"LA Samsa","year":"2015","unstructured":"Samsa LA, Givens C, Tzima E, Stainier DYR, Qian L, Liu J (2015) Cardiac contraction activates endocardial notch signaling to modulate chamber maturation in zebrafish. Development 142:4080\u20134091. \n                    https:\/\/doi.org\/10.1242\/dev.125724","journal-title":"Development"},{"key":"1193_CR33","doi-asserted-by":"publisher","first-page":"19071","DOI":"10.1073\/pnas.1310905110","volume":"110","author":"Y Yao","year":"2013","unstructured":"Yao Y, Yao J, Radparvar M, Blazquez-Medela AM, Guihard PJ, Jumabay M, Bostrom KI (2013) Reducing jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency. Proc Natl Acad Sci U S A 110:19071\u201319076. \n                    https:\/\/doi.org\/10.1073\/pnas.1310905110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1193_CR34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.stem.2010.11.009","volume":"7","author":"T Nomura","year":"2010","unstructured":"Nomura T, G\u00f6ritz C, Catchpole T, Henkemeyer M, Fris\u00e9n J (2010) EphB signaling controls lineage plasticity of adult neural stem cell niche cells. Cell Stem Cell 7:730\u2013743. \n                    https:\/\/doi.org\/10.1016\/j.stem.2010.11.009","journal-title":"Cell Stem Cell"},{"key":"1193_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.biopsych.2017.11.020","volume":"83","author":"SA Purro","year":"2018","unstructured":"Purro SA, Nicoll AJ, Collinge J (2018) Prion protein as a toxic acceptor of amyloid-\u03b2 oligomers. Biol Psychiatry 83:358\u2013368. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2017.11.020","journal-title":"Biol Psychiatry"},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/nan.12019","volume":"39","author":"M Qu","year":"2013","unstructured":"Qu M, Jiang J, Liu X-P, Tian Q, Chen LM, Yin G, Liu D, Wang JZ et al (2013) Reduction and the intracellular translocation of EphB2 in Tg2576 mice and the effects of \u03b2-amyloid. Neuropathol Appl Neurobiol 39:612\u2013622. \n                    https:\/\/doi.org\/10.1111\/nan.12019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1193_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3233\/JAD-2009-1096","volume":"17","author":"AM Sim\u00f3n","year":"2009","unstructured":"Sim\u00f3n AM, de Maturana RL, Ricobaraza A et al (2009) Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer\u2019s disease. J Alzheimers Dis JAD 17:773\u2013786. \n                    https:\/\/doi.org\/10.3233\/JAD-2009-1096","journal-title":"J Alzheimers Dis JAD"},{"key":"1193_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature09635","volume":"469","author":"M Ciss\u00e9","year":"2011","unstructured":"Ciss\u00e9 M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G et al (2011) Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469:47\u201352. \n                    https:\/\/doi.org\/10.1038\/nature09635","journal-title":"Nature"},{"key":"1193_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004662","volume":"11","author":"US Herrmann","year":"2015","unstructured":"Herrmann US, Sonati T, Falsig J, Reimann RR, Dametto P, O\u2019Connor T, Li B, Lau A et al (2015) Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways. PLoS Pathog 11:e1004662. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1004662","journal-title":"PLoS Pathog"},{"key":"1193_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003002","volume":"8","author":"A Majer","year":"2012","unstructured":"Majer A, Medina SJ, Niu Y, Abrenica B, Manguiat KJ, Frost KL, Philipson CS, Sorensen DL et al (2012) Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog 8:e1003002. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1003002","journal-title":"PLoS Pathog"},{"key":"1193_CR41","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1038\/cddis.2012.195","volume":"4","author":"E Pradines","year":"2013","unstructured":"Pradines E, Hernandez-Rapp J, Villa-Diaz A, Dakowski C, Ardila-Osorio H, Haik S, Schneider B, Launay JM et al (2013) Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance. Cell Death Dis 4:e456. \n                    https:\/\/doi.org\/10.1038\/cddis.2012.195","journal-title":"Cell Death Dis"},{"key":"1193_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"D-M Chuang","year":"2009","unstructured":"Chuang D-M, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32:591\u2013601. \n                    https:\/\/doi.org\/10.1016\/j.tins.2009.06.002","journal-title":"Trends Neurosci"},{"key":"1193_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molonc.2014.08.016","volume":"9","author":"K R\u00f6nsch","year":"2015","unstructured":"R\u00f6nsch K, J\u00e4gle S, Rose K, Seidl M, Baumgartner F, Freihen V, Yousaf A, Metzger E et al (2015) SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer. Mol Oncol 9:335\u2013354. \n                    https:\/\/doi.org\/10.1016\/j.molonc.2014.08.016","journal-title":"Mol Oncol"},{"key":"1193_CR44","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bjc.6602309","volume":"92","author":"M-T Stockhausen","year":"2005","unstructured":"Stockhausen M-T, Sj\u00f6lund J, Manetopoulos C, Axelson H (2005) Effects of the histone deacetylase inhibitor valproic acid on notch signalling in human neuroblastoma cells. Br J Cancer 92:751\u2013759. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6602309","journal-title":"Br J Cancer"},{"key":"1193_CR45","doi-asserted-by":"publisher","first-page":"610","DOI":"10.4161\/epi.6.5.15300","volume":"6","author":"K R\u00f6nsch","year":"2011","unstructured":"R\u00f6nsch K, J\u00e4ger M, Sch\u00f6pflin A, Danciu M, La\u00dfmann S, Hecht A (2011) Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer. Epigenetics 6:610\u2013622","journal-title":"Epigenetics"},{"key":"1193_CR46","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1634\/theoncologist.2011-0031","volume":"16","author":"TA Mohammed","year":"2011","unstructured":"Mohammed TA, Holen KD, Jaskula-Sztul R, Mulkerin D, Lubner SJ, Schelman WR, Eickhoff J, Chen H et al (2011) A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist 16:835\u2013843. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2011-0031","journal-title":"Oncologist"},{"key":"1193_CR47","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741. \n                    https:\/\/doi.org\/10.1074\/jbc.M101287200","journal-title":"J Biol Chem"},{"key":"1193_CR48","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1073\/pnas.262658999","volume":"99","author":"L Tremolizzo","year":"2002","unstructured":"Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, Sharma R, Grayson DR et al (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 99:17095\u201317100. \n                    https:\/\/doi.org\/10.1073\/pnas.262658999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1193_CR49","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1073\/pnas.0408612101","volume":"102","author":"N Ishikura","year":"2005","unstructured":"Ishikura N, Clever JL, Bouzamondo-Bernstein E, Samayoa E, Prusiner SB, Huang EJ, DeArmond SJ (2005) Notch-1 activation and dendritic atrophy in prion disease. Proc Natl Acad Sci U S A 102:886\u2013891. \n                    https:\/\/doi.org\/10.1073\/pnas.0408612101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1193_CR50","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1073\/pnas.0803671105","volume":"105","author":"P Spilman","year":"2008","unstructured":"Spilman P, Lessard P, Sattavat M, Bush C, Tousseyn T, Huang EJ, Giles K, Golde T et al (2008) A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc Natl Acad Sci U S A 105:10595\u201310600. \n                    https:\/\/doi.org\/10.1073\/pnas.0803671105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1193_CR51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm.2016.94","volume":"17","author":"SJ Bray","year":"2016","unstructured":"Bray SJ (2016) Notch signalling in context. Nat Rev Mol Cell Biol 17:722\u2013735. \n                    https:\/\/doi.org\/10.1038\/nrm.2016.94","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1193_CR52","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1523\/JNEUROSCI.4876-11.2012","volume":"32","author":"M Wu","year":"2012","unstructured":"Wu M, Hernandez M, Shen S, Sabo JK, Kelkar D, Wang J, O'Leary R, Phillips GR et al (2012) Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. J Neurosci 32:6651\u20136664. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4876-11.2012","journal-title":"J Neurosci"},{"key":"1193_CR53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neuron.2011.01.004","volume":"69","author":"L Alberi","year":"2011","unstructured":"Alberi L, Liu S, Wang Y, Badie R, Smith-Hicks C, Wu J, Pierfelice TJ, Abazyan B et al (2011) Activity-induced notch signaling in neurons requires arc\/Arg3.1 and is essential for synaptic plasticity in hippocampal networks. Neuron 69:437\u2013444. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.01.004","journal-title":"Neuron"},{"key":"1193_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003485","volume":"9","author":"A Relano-Gines","year":"2013","unstructured":"Relano-Gines A, Gabelle A, Hamela C et al (2013) Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: Involvement of endogenous neural stem cells in prion diseases. PLoS Pathog 9:e1003485. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1003485","journal-title":"PLoS Pathog"},{"key":"1193_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature09938","volume":"473","author":"BK Attwood","year":"2011","unstructured":"Attwood BK, Bourgognon J-M, Patel S, Mucha M, Schiavon E, Skrzypiec AE, Young KW, Shiosaka S et al (2011) Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473:372\u2013375. \n                    https:\/\/doi.org\/10.1038\/nature09938","journal-title":"Nature"},{"key":"1193_CR56","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jalz.2016.05.006","volume":"12","author":"A Herring","year":"2016","unstructured":"Herring A, M\u00fcnster Y, Akkaya T, Moghaddam S, Deinsberger K, Meyer J, Zahel J, Sanchez-Mendoza E et al (2016) Kallikrein-8 inhibition attenuates Alzheimer\u2019s disease pathology in mice. Alzheimers Dement 12:1273\u20131287. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.05.006","journal-title":"Alzheimers Dement"},{"key":"1193_CR57","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978. \n                    https:\/\/doi.org\/10.1093\/emboj\/20.24.6969","journal-title":"EMBO J"},{"key":"1193_CR58","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ana.10298","volume":"52","author":"GM Shaked","year":"2002","unstructured":"Shaked GM, Engelstein R, Avraham I, Rosenmann H, Gabizon R (2002) Valproic acid treatment results in increased accumulation of prion proteins. Ann Neurol 52:416\u2013420. \n                    https:\/\/doi.org\/10.1002\/ana.10298","journal-title":"Ann Neurol"},{"key":"1193_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF03033916","volume":"12","author":"C Legendre","year":"2007","unstructured":"Legendre C, Casagrande F, Andrieu T, Dormont D, Clayette P (2007) Sodium valproate does not augment Prpsc in murine neuroblastoma cells. Neurotox Res 12:205\u2013208","journal-title":"Neurotox Res"},{"key":"1193_CR60","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neuropharm.2015.06.013","volume":"101","author":"RSB Williams","year":"2016","unstructured":"Williams RSB, Bate C (2016) An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling. Neuropharmacology 101:566\u2013575. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.013","journal-title":"Neuropharmacology"},{"key":"1193_CR61","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.bbagrm.2016.08.002","volume":"1859","author":"O Schnappauf","year":"2016","unstructured":"Schnappauf O, Beyes S, Dertmann A, Freihen V, Frey P, J\u00e4gle S, Rose K, Michoel T et al (2016) Enhancer decommissioning by Snail1-induced competitive displacement of TCF7L2 and down-regulation of transcriptional activators results in EPHB2 silencing. Biochim Biophys Acta 1859:1353\u20131367. \n                    https:\/\/doi.org\/10.1016\/j.bbagrm.2016.08.002","journal-title":"Biochim Biophys Acta"},{"key":"1193_CR62","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, Rumbaugh G (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 35:870\u2013880. \n                    https:\/\/doi.org\/10.1038\/npp.2009.197","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"1193_CR63","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10571-013-0012-y","volume":"34","author":"Z-G Yao","year":"2014","unstructured":"Yao Z-G, Liang L, Liu Y, Zhang L, Zhu H, Huang L, Qin C (2014) Valproate improves memory deficits in an Alzheimer\u2019s disease mouse model: Investigation of possible mechanisms of action. Cell Mol Neurobiol 34:805\u2013812. \n                    https:\/\/doi.org\/10.1007\/s10571-013-0012-y","journal-title":"Cell Mol Neurobiol"},{"key":"1193_CR64","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/jphp.12800","volume":"69","author":"SF Tan","year":"2017","unstructured":"Tan SF, Kirby BP, Stanslas J, Basri HB (2017) Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability. J Pharm Pharmacol 69:1447\u20131457. \n                    https:\/\/doi.org\/10.1111\/jphp.12800","journal-title":"J Pharm Pharmacol"},{"key":"1193_CR65","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA, Nygaard HB et al (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128\u20131132","journal-title":"Nature"},{"key":"1193_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuropharm.2014.01.038","volume":"80","author":"A Fischer","year":"2014","unstructured":"Fischer A (2014) Targeting histone-modifications in Alzheimer\u2019s disease. What is the evidence that this is a promising therapeutic avenue? Neuropharmacology 80:95\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.038","journal-title":"Neuropharmacology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1193-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T15:38:28Z","timestamp":1568993908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1193-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1193-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"1 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}